CDMOs

CDMOs

featured image of Mastering Advanced Therapies: Key Insights for Success!

Mastering Advanced Therapies: Key Insights for Success!

BIOT

Unlock the secrets of advanced therapy processes! 🧬 Early insights and GMP alignment are essential for success. 📝💡

featured image of Powerful Pharma Partnership Boosts US Manufacturing!

Powerful Pharma Partnership Boosts US Manufacturing!

BIOT

🌟 Recipharm and Exela Pharma join forces! 🏭 This alliance boosts sterile manufacturing in the U.S. 💉 Exciting biopharmaceuticals ahead! 📈🤝

featured image of Unlocking Biotech: Why CDMOs Must Embrace Innovation!

Unlocking Biotech: Why CDMOs Must Embrace Innovation!

BIOT

🌍 CDMOs must showcase new bioprocessing tech benefits to win over clients. 💰 Larger firms hesitate, while smaller ones embrace innovation. 🤝

featured image of 2024's Top CDMOs: Leaders and Challenges Ahead!

2024’s Top CDMOs: Leaders and Challenges Ahead!

BIOT

**Excerpt:** Discover the top 10 CDMOs for 2024! 🌟 Lonza, Thermo Fisher, and Catalent lead the way amidst industry challenges. 📈⚠️

featured image of Agilent's $925M Biovectra Buy: Boosting Growth!

Agilent’s $925M Biovectra Buy: Boosting Growth!

BIOT

Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦

featured image of Revolutionary Company Solves Manufacturing Failures for Gene Therapy

Revolutionary Company Solves Manufacturing Failures for Gene Therapy

BIOT

📢 Introducing Bespark*bio: Tackling manufacturing failures in gene therapy to bring life-saving treatments to the market! 🏭💡💉

featured image of CDMO Incog Supercharges Operations with $75M Expansion

CDMO Incog Supercharges Operations with $75M Expansion

BIOT

🔧 CDMO Incog gears up with 💰$75m expansion to boost filling capacity. Exciting times ahead! 🚀🔬👩‍🔬 pharmaceuticals growth

featured image of CDMO Leadership Shuffles: Impact on Biotech

CDMO Leadership Shuffles: Impact on Biotech

BIOT

📌 Explore the impact of leadership shuffles at CDMOs in the biotech industry 🌍🔬. Find out why stability matters!

featured image of Biogen's CDMO Revenues Set to Plummet!

Biogen’s CDMO Revenues Set to Plummet!

BIOT

📢 Biogen, a global biotech company, anticipates a decline in CDMO revenues as its Denmark commitments conclude. 😔

featured image of Game-Changing Merger Propels Biovian and 3P Globally

Game-Changing Merger Propels Biovian and 3P Globally

BIOT

🔎 CDMOs Biovian and 3P merge to expand globally, covering the entire biotech development process. 🌍💼🤝📈

12 Next